兰州大学学报（医学版）2024，Vol.50Issue(1)：52-60,81,10.DOI:10.13885/j.issn.1000-2812.2024.01.008
静脉注射免疫球蛋白治疗儿童川崎病的循证指南(2023)
Evidence-based guideline for intravenous immunoglobulin treatment of Kawasaki disease in children(2023)
摘要
Abstract
The incidence of Kawasaki disease(KD)has increased in China,and intravenous immunoglobulin(IVIG)is a first-line treatment for KD.Current guidelines on KD mostly focus on its diagnosis,while guide-lines on IVIG for KD still lack evidence support.This guideline refers to the World Health Organisation Hand-book for Guideline Development and Guidelines for the Development/Revision of Clinical Practice Guide-lines in China(2022 edition).In this study a questionnaire was administered to pediatricians and clinical phar-macists to identify 10 clinical questions.Ten recommendations on IVIG for KD in children were finalized through Delphi based on available evidence,as well as the values of patient preferences,the cost,the balance of pros and cons,and accessibility of interventions.The guideline is applicable to clinicians and pharmacists working on KD in all levels of hospitals.关键词
儿科/川崎病/静脉注射免疫球蛋白/循证指南Key words
pediatric/Kawasaki disease/intravenous immunoglobulin/evidence-based guideline分类
医药卫生引用本文复制引用
雷文娟,魏玉辉,杨彦彪,张红梅,戴永利,周素琴,刘静,王法琴,雷晓燕,王建军,陶仲宾,周奇,杨轶男,王卫凯,徐瑞峰,马建丽,张海平,李丽亚,汤兴萍,王向东,李哲玮,邵婷玑,高琲,辛明彦,孟敏,葛斌,赵俊贤,刘辉,田敏,贾忠,王荣,虎亚光..静脉注射免疫球蛋白治疗儿童川崎病的循证指南(2023)[J].兰州大学学报（医学版）,2024,50(1):52-60,81,10.基金项目
甘肃省人民医院院内科研基金资助项目(23GSSYC-8) （23GSSYC-8）
2021年度甘肃省药品临床综合评价工作资助项目 （）
